CBD for Individuals at Risk for Alzheimer's Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CBD for Individuals at Risk for Alzheimer's Disease — Stella

Recruiting

Back to Mild Cognitive Impairment trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Colorado - Anschutz Medical Campus, Aurora, Colorado

Key details

Phase

Safety & dosing

Sponsor

University of Colorado, Denver

Enrollment target

~236 participants

Started

January 2024

Primary completion

April 2028

Age range

55 Years – 85 Years

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov